176 related articles for article (PubMed ID: 18651761)
1. Overexpression of Rho GDP-dissociation inhibitor alpha is associated with tumor progression and poor prognosis of colorectal cancer.
Zhao L; Wang H; Li J; Liu Y; Ding Y
J Proteome Res; 2008 Sep; 7(9):3994-4003. PubMed ID: 18651761
[TBL] [Abstract][Full Text] [Related]
2. Overexpression of RhoGDI2 correlates with tumor progression and poor prognosis in colorectal carcinoma.
Li X; Wang J; Zhang X; Zeng Y; Liang L; Ding Y
Ann Surg Oncol; 2012 Jan; 19(1):145-53. PubMed ID: 21861235
[TBL] [Abstract][Full Text] [Related]
3. Stathmin, a new target of PRL-3 identified by proteomic methods, plays a key role in progression and metastasis of colorectal cancer.
Zheng P; Liu YX; Chen L; Liu XH; Xiao ZQ; Zhao L; Li GQ; Zhou J; Ding YQ; Li JM
J Proteome Res; 2010 Oct; 9(10):4897-905. PubMed ID: 20806969
[TBL] [Abstract][Full Text] [Related]
4. The RhoGDI-alpha/JNK signaling pathway plays a significant role in mycophenolic acid-induced apoptosis in an insulin-secreting cell line.
Park YJ; Ahn HJ; Chang HK; Kim JY; Huh KH; Kim MS; Kim YS
Cell Signal; 2009 Feb; 21(2):356-64. PubMed ID: 19041939
[TBL] [Abstract][Full Text] [Related]
5. Proteome analysis and tissue microarray for profiling protein markers associated with lymph node metastasis in colorectal cancer.
Pei H; Zhu H; Zeng S; Li Y; Yang H; Shen L; Chen J; Zeng L; Fan J; Li X; Gong Y; Shen H
J Proteome Res; 2007 Jul; 6(7):2495-501. PubMed ID: 17542627
[TBL] [Abstract][Full Text] [Related]
6. Promotion of colorectal cancer growth and metastasis by the LIM and SH3 domain protein 1.
Zhao L; Wang H; Liu C; Liu Y; Wang X; Wang S; Sun X; Li J; Deng Y; Jiang Y; Ding Y
Gut; 2010 Sep; 59(9):1226-35. PubMed ID: 20660701
[TBL] [Abstract][Full Text] [Related]
7. Node-negative colorectal cancer at high risk of distant metastasis identified by combined analysis of lymph node status, vascular invasion, and Raf-1 kinase inhibitor protein expression.
Zlobec I; Baker K; Minoo P; Jass JR; Terracciano L; Lugli A
Clin Cancer Res; 2008 Jan; 14(1):143-8. PubMed ID: 18172264
[TBL] [Abstract][Full Text] [Related]
8. Rho GDP dissociation inhibitor protects cancer cells against drug-induced apoptosis.
Zhang B; Zhang Y; Dagher MC; Shacter E
Cancer Res; 2005 Jul; 65(14):6054-62. PubMed ID: 16024605
[TBL] [Abstract][Full Text] [Related]
9. Proteomic analysis of Tiam1-mediated metastasis in colorectal cancer.
Liu L; Zhao L; Zhang Y; Zhang Q; Ding Y
Cell Biol Int; 2007 Aug; 31(8):805-14. PubMed ID: 17376711
[TBL] [Abstract][Full Text] [Related]
10. Expression of alpha-, beta- and gamma-synuclein in colorectal cancer, and potential clinical significance in progression of the disease.
Ye Q; Wang TF; Peng YF; Xie J; Feng B; Qiu MY; Li LH; Lu AG; Liu BY; Zheng MH
Oncol Rep; 2010 Feb; 23(2):429-36. PubMed ID: 20043104
[TBL] [Abstract][Full Text] [Related]
11. Tumor beta-1,4-galactosyltransferase IV overexpression is closely associated with colorectal cancer metastasis and poor prognosis.
Chen WS; Chang HY; Li CP; Liu JM; Huang TS
Clin Cancer Res; 2005 Dec; 11(24 Pt 1):8615-22. PubMed ID: 16361545
[TBL] [Abstract][Full Text] [Related]
12. 14-3-3sigma expression is an independent prognostic parameter for poor survival in colorectal carcinoma patients.
Perathoner A; Pirkebner D; Brandacher G; Spizzo G; Stadlmann S; Obrist P; Margreiter R; Amberger A
Clin Cancer Res; 2005 May; 11(9):3274-9. PubMed ID: 15867223
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of hepatic-metastasis risk of colorectal cancer upon the protein signature of PI3K/AKT pathway.
Kang B; Hao C; Wang H; Zhang J; Xing R; Shao J; Li W; Xu N; Lu Y; Liu S
J Proteome Res; 2008 Aug; 7(8):3507-15. PubMed ID: 18570457
[TBL] [Abstract][Full Text] [Related]
14. Reduced expression of Rho guanine nucleotide dissociation inhibitor-alpha modulates the cytotoxic effect of busulfan in HEK293 cells.
Reimer J; Bien S; Sonnemann J; Beck JF; Wieland T; Kroemer HK; Ritter CA
Anticancer Drugs; 2007 Mar; 18(3):333-40. PubMed ID: 17264767
[TBL] [Abstract][Full Text] [Related]
15. Identification of metastasis-associated proteins involved in gallbladder carcinoma metastasis by proteomic analysis and functional exploration of chloride intracellular channel 1.
Wang JW; Peng SY; Li JT; Wang Y; Zhang ZP; Cheng Y; Cheng DQ; Weng WH; Wu XS; Fei XZ; Quan ZW; Li JY; Li SG; Liu YB
Cancer Lett; 2009 Aug; 281(1):71-81. PubMed ID: 19299076
[TBL] [Abstract][Full Text] [Related]
16. Comparative proteomic analysis identifies proteins associated with the development and progression of colorectal carcinoma.
Zhao L; Wang H; Sun X; Ding Y
FEBS J; 2010 Oct; 277(20):4195-204. PubMed ID: 20812987
[TBL] [Abstract][Full Text] [Related]
17. Podoplanin expression identified in stromal fibroblasts as a favorable prognostic marker in patients with colorectal carcinoma.
Yamanashi T; Nakanishi Y; Fujii G; Akishima-Fukasawa Y; Moriya Y; Kanai Y; Watanabe M; Hirohashi S
Oncology; 2009; 77(1):53-62. PubMed ID: 19556810
[TBL] [Abstract][Full Text] [Related]
18. Overexpression of RhoGDI, a novel predictor of distant metastasis, promotes cell proliferation and migration in hepatocellular carcinoma.
Wang H; Wang B; Liao Q; An H; Li W; Jin X; Cui S; Zhao L
FEBS Lett; 2014 Jan; 588(3):503-8. PubMed ID: 24374343
[TBL] [Abstract][Full Text] [Related]
19. Rho GDP-dissociation inhibitor alpha is associated with cancer metastasis in colon and prostate cancer.
Yamashita T; Okamura T; Nagano K; Imai S; Abe Y; Nabeshi H; Yoshikawa T; Yoshioka Y; Kamada H; Tsutsumi Y; Tsunoda S
Pharmazie; 2012 Mar; 67(3):253-5. PubMed ID: 22530308
[TBL] [Abstract][Full Text] [Related]
20. A colorectal cancer expression profile that includes transforming growth factor beta inhibitor BAMBI predicts metastatic potential.
Fritzmann J; Morkel M; Besser D; Budczies J; Kosel F; Brembeck FH; Stein U; Fichtner I; Schlag PM; Birchmeier W
Gastroenterology; 2009 Jul; 137(1):165-75. PubMed ID: 19328798
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
